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Case Report
Continuous Ambulatory Peritoneal Dialysis (CAPD) associated peritonitis in a
child: a rare case of peritonitis caused by sphingomonous paucimobilis
Arwa Quresh Tambawala,1 Sadaf Hamid,2 Iqtidar Khan,3 Asad Ali4
AKUH,1,2 Department of Paediatrics and Child Health,3,4 Aga Khan University and Hospital (AKUH), Karachi, Pakistan.

Abstract
First identified in 1977, Sphingomonous Paucimobilis
has emerged as an opportunistic human pathogen. It is primarily
known to cause a range of mostly nosocomial, non-lifethreatening infections that typically are easily treated by
antibiotic therapy. Sources of its isolation linked to clinical
disease include blood, spinal fluid and leg ulcers. It has also been
reported as a rare cause of peritonitis in patients on continuous
ambulatory peritoneal dialysis. We present a case of a child with
peritonitis due to this organism. Clinical features, bacteriology
and treatment option and response have been discussed.
Keywords: CAPD, Sphingomonous paucimobilis, Peritonitis.

Introduction
The invention of Continuous Ambulatory Peritoneal
Dialysis (CAPD) in 1976 lead to a significant increase in the
utilization of the peritoneal dialysis (PD).1 At present, over
130,000 patients are on CAPD worldwide, accounting for
15% of the total dialysis population.2 The increasing
popularity of CAPD is attributed to the convenience of home
administration and similar and even superior survival in the
first 2 to 3years.2,3 In Pakistan, CAPD is being performed for
the last few years with more than 100 patients in Karachi,
Lahore, Peshawar and Dera Ismail Khan3 However, it is not
as popular in Pakistan as compared to many other countries,
because of the higher cost of dialysis solution and the
relatively higher risk of infections, if infection control
practices are compromised.4
Peritonitis is one of the major complications of PD,
including CAPD. It is the main reason why patients switch from
PD to haemodialysis (HD).5,6 The overwhelming majority of
peritonitis cases are caused by pathogenic bacteria, with a small
number of cases being caused by fungi, mostly Candida species.7
Databases from U.S.A and Canada show that gram positive
organisms account for 62 and 61 percent of PD associated
peritonitis, while gram negative bacteria are responsible for 21
and 24 percent of PD associated peritonitis in these countries
respectively. Fungal peritonitis causes slightly less than 4 percent
of PD associated peritonitis in both countries.8
We report a case of a child who developed CAPD
associated peritonitis due to a rare organism, sphingomonous
paucimobilis. The child was treated initially with
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intraperitoneal amikacin but on developing impaired hearing
was switched to IV meropenem to which he responded. To
our knowledge this is the first case report from Pakistan and
the second reported case of peritonitis due sphingomonous
paucimobilis which was treated with IV carbapenem.

Case Report
Patient was a 3 ½ year old boy, known case of endstage renal disease secondary to Prune Belly syndrome, who
was on CAPD since November 2007. He presented on
14/01/09 with one-month history of a cloudy peritoneal
effluent and decreased oral intake, oral ulcers and perineal
rash for the past 5 days. His last admission was from 03/01/09
to 09/01/09 with complaints of altered peritoneal effluent,
abdominal pain, and fever. He was diagnosed as spontaneous
bacterial peritonitis in the last admission and treated with IV
Ceftriaxone, to which the child responded clinically but the
peritoneal effluent did not clear completely. His peritoneal
D/R in the previous admission showed Glucose: 742mg/dl;
Protein: 169mg/dl and white blood cell count: 500;
Neutrophils: 60% and Lymphocytes: 40%. After he was
discharged, his peritoneal fluid culture showed growth of
sphingomonous paucimobilis. Because of the persistent
cloudy dialysate and positive culture, patient was readmitted
for treatment of peritonitis.
On examination the child was pale looking, mildly
dehydrated and had multiple oral ulcers. His vitals were
within normal limits. His abdomen was soft, non-tender, liver
and spleen were not palpable and a CAPD catheter was in
place. The rest of the examination was unremarkable.
Lab investigations in that admission showed a
Haemoglobin(Hb)/Hematocrit: 8.4g/dl/26.4%; White blood
cell count: 7.7; neutrophils(N):51% and Lymphocytes:32%;
Platelets:644000.
The peritoneal effluent was sent for investigation. The
gram stain of peritoneal smear revealed gram negative rods.
The peritoneal detail report showed Glucose: 853mg/dl,
Protein: 93mg/dl and WBC: 600; neutrophils: 80%;
lymphocytes: 20%. The peritoneal fluid was inoculated on
5%sheep blood agar, Chocolate agar and MacConkeys agar.
Cultures of the peritoneal dialysate on 5% sheep blood agar
and chocolate agar grew small colonies at 24 hours of growth,
at 37ºC but not at 42ºC, aerobically. The colonies were
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pigmented an ochre-yellow. The MacConkeys agar showed
no growth. The bacteria were gram negative, non-fermenting,
and oxidase and catalase positive. The organisms were
motile. The isolates were identified as Sphingomonas
paucimobilis through use of the API 20NE (BioMèrieux).Sensitivities were checked by the disc diffusion
method. The organism was sensitive to amikacin,
meropenem, tetracycline and polymixin B. It was resistant to
aztreonam, ceftazidime, gentamicin, ceftriaxone, ofloxacin,
ciprofloxacin, cotrimoxazole and cefixime. Cultures were
positive at 24 hours.

Hospital Course:
Based on the presentation and the investigations the
boy was diagnosed of having moderate peritonitis with a
single low virulence organism known as Sphingomonous
Paucimobilis. According to the culture and sensitivity report
the boy was started on intraperitoneal amikacin (day/date).
On day-1 a loading dose of 2mg/kg/bag of amikacin (250mg
in 2L of dialysis solution) was given once. The plan was to
keep a maintenance dose of 50mg/2L bag from day 2
onwards for 14 days, aiming for a trough level of 2mg/l.
A repeat peritoneal D/R on 22/01/09 showed few pus
cells, Glucose: 144mg/d and Proteins: 90mg/dl. The culture
of the same day reported no growth of the organism.
On day 4 of treatment with intraperitoneal amikacin,
parents noticed that the boy had decreased hearing. There
after amikacin was stopped and a BERA was obtained which
showed absence of any reproducible response with a stimulus
intensity of up to 105DB. Baseline hearing assessment, prior
to the initiation of Amikacin was not available. The child was
then placed on intravenous meropenem for 7days. The child
recovered with clearing of dialysate fluid and he was
discharged on 26/01/09.

Discussion
Sphingomonous paucimobilis is a nonfermentative,
gram negative, motile bacterium that produces yellowpigmented colonies on culture. It was first isolated in a
human infection in 1977 and named Pseudomonas
paucimobilis. It was reclassified in 1990 based upon
phylogenetic data and renamed Sphingomonas
paucimobilis,9,10 The natural habitat of this organism has not
been totally defined but it is widely distributed in the
environment especially in the water and soil. It has also been
recovered from hospital environments including tap water,
distilled water, nebulizers, respirators, dialysis fluid and other
equipment.11,12
Sphingomonous paucimobilis is an unusual pathogen
for PD associated peritonitis. The first two cases of PDassociated peritonitis caused by S. paucimobilis (as P.
paucimobilis) were reported by Glupczynski et al12 in 1984.
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Thereafter, 6 more cases have been reported with the latest by
Dervisoglu et al in 2008.13 Peritonitis due to this organism
tends to have a variable course as is evident from the previous
case reports. It causes a mild to moderate peritonitis and
patients at the time of presentation are clinically stable and
often afebrile. Abdominal pain and cloudy dialysate are the
usual presenting symptoms. Our patient presented with only
a cloudy peritoneal effluent without any systemic signs of
illness. It is interesting that the child seemingly responded to
IV Ceftriaxone in the previous admission, even though the
sphingomonas was resistant to ceftriaxone. Perhaps this was
because of the indolent nature of organism, or perhaps there
was a co-infection at that time with an organism that was
treated by ceftriaxone.
The clinical outcomes in the reported cases so far have
been variable, with some cases responding to antibiotics only
while others eventually requiring catheter removal. Most of
the latter patients had clinically improved with antibiotics but
continued to have positive cultures. Our patient fortunately
responded to antibiotics and became culture negative. The
organism also tends to have unpredictable drug sensitivity.
None of the case reports have shown any consistent pattern of
sensitivity. Hence to date, no definitive guidelines exist for
antimicrobial therapy for Sphingomonas infections.
Potentially
active
agents
include
TMP-SMX,
chloramphenicol, ciprofloxacin, and aminoglycosides.14
Imipenem alone and an aminoglycoside plus a thirdgeneration cephalosporin have been suggested as suitable
antibiotics for the treatment of susceptible sphingomonas
infections.11 In previously reported PD-associated peritonitis
cases, antibiotic resistance during monotherapy was not
noted. We used monotherapy with IV meropenem and were
successful in eradicating the infection.

Conclusion
In summary, our report shows that sphingomonas
paucimobilis can be a possible organism responsible for
CAPD associated peritonitis. This organism is mostly
resistant to the common antibiotics empirically used to treat
peritonitis. If susceptible, IV meropenem can be considered
for the treatment of this indolent but hard to treat infection.
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